Search Results - "Braakman, Rene BH"

The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies by De Marchi, Tommaso, Braakman, Rene B. H., Stingl, Christoph, van Duijn, Martijn M., Smid, Marcel, Foekens, John A., Luider, Theo M., Martens, John W. M., Umar, Arzu

“…Laser‐capture microdissection (LCM) offers a reliable cell population enrichment tool and has been successfully coupled to MS analysis. Despite this, most…”
Get full text

Proteomic characterization of microdissected breast tissue environment provides a protein‐level overview of malignant transformation by Braakman, René B. H., Stingl, Christoph, Tilanus‐Linthorst, Madeleine M. A., van Deurzen, Carolien H. M., Timmermans, Mieke A. M., Smid, Marcel, Foekens, John A., Luider, Theo M., Martens, John W. M., Umar, Arzu

“…Both healthy and cancerous breast tissue is heterogeneous, which is a bottleneck for proteomics‐based biomarker analysis, as it obscures the cellular origin of…”
Get full text

Abstract 1611: 4-protein signature predicts outcome to tamoxifen treatment in estrogen receptor positive recurrent breast cancer by Marchi, Tommaso De, Liu, NingQing, Tjoa, Mila, Stingl, Christoph, Smid, Marcel, Look, Maxime P., Timmermans, Mieke A., Braakman, Rene BH, Opdam, Mark, Linn, Sabine, Span, Paul, Sweep, Fred CGJ, Martens, John WM, Luider, Theo M., Foekens, John A., Umar, Arzu

“…Abstract Tamoxifen is one of the most frequently used drugs in the treatment of estrogen receptor positive breast cancer. Although tamoxifen significantly…”
Get full text

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer by NING QING LIU, STINGL, Christoph, MANGIA, Anita, PARADISO, Angelo, DIRIX, Luc Y, VAN LAERE, Steven J, LUIDER, Theo M, MARTENS, John W. M, FOEKENS, John A, UMAR, Arzu, LOOK, Maxime P, SMID, Marcel, BRAAKMAN, René B. H, DE MARCHI, Tommaso, SIEUWERTS, Anieta M, SPAN, Paul N, SWEEP, Fred C. G. J, LINDERHOLM, Barbro K

“…Clinical outcome of patients with triple-negative breast cancer (TNBC) is highly variable. This study aims to identify and validate a prognostic protein…”
Get full text

Abstract P4-09-03: Comparative proteomic analysis identifies a 15-protein signature related to clinical outcome of triple negative breast cancer by Liu, Ning Qing, De Marchi, Tommaso, Stingl, Christoph, Timmermans, Annemieke M, Look, Maxime P, Braakman, René BH, Smid, Marcel, Foekens, Renée, Trapman, Anita MAC, Luider, Theo M, Martens, John WM, Foekens, John A, Umar, Arzu

“…Abstract Withdrawn by Author Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P4-09-03…”
Get full text